What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…

What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…

What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…

What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…

What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…

What the latest Johnson & Johnson COVID vaccine…

Some have raised concerns that one of Johnson & Johnson's previously reported vaccine data points -- a 66% global efficacy in preventing moderately symptomatic disease -- doesn't seem as impressive as figures reported by Pfizer…